Sign in
Enrolling by invitationNo phase

Spinal stimulation with electrically assisted cough training after recent spinal cord injury

Tests spinal stimulation plus assisted cough training in adults with recent spinal cord injury.

Key facts

Who runs it
Milap Sandhu
Where
Chicago, United StatesSee the site
Trial code
Registry title
Spinal Stimulation + FES-Assisted Cough Training in SCI
Status
Enrolling by invitation
People taking part
60 people, planned
Started
15 Jun 2026
Expected to end
Jan 2030
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • tSCS combined with FES-Cough
  • Sham tSCS + FES assisted cough
Record updated
6 July 2026

Who can take part

The trial is looking for adults with a recent traumatic spinal cord injury at the neck or upper chest level and a weak cough. They must be in inpatient rehabilitation at Shirley Ryan AbilityLab.

Age
18 Years to 65 Years
Sex
All sexes can join.
Disease stage
Traumatic spinal cord injury at level C1-T1, AIS A-C on the admission exam. Enrolment between 14-60 days after the injury.
Earlier treatment
People currently in another interventional research study cannot join.
Biomarker or test result
Baseline peak cough flow (PCF) below 270 L/min. Breathing through the normal airway, or tolerating a closed tracheostomy (speaking valve or cap) for at least 60 minutes.
Main reasons for not taking part
  • Long-term lung disease from before the injury, or needing a ventilator during the day
  • Moderate to severe brain injury, active cancer, or uncontrolled autonomic dysreflexia (sudden dangerous blood pressure spikes)
  • Pacemaker, implanted defibrillator, deep brain stimulator, diaphragm pacer, or uncontrolled seizures
  • Pregnancy, severe osteoporosis, unhealed rib fracture, or recent collapsed lung
  • Unable to sit upright more than 45 degrees for 15 minutes, or wearing a halo spine brace
Show the full registry criteria (10)Hide the full registry criteria

Who can take part

  • Currently admitted for inpatient rehabilitation at Shirley Ryan AbilityLab
  • History of traumatic spinal cord injury with Neurologic Level of Injury (NLI) C1-T1, and AIS A-C on admission exam
  • Between 14-60 days from date of injury at time of enrollment
  • Baseline PCF below 270 L/min
  • Anatomical airway or tolerating occlusion of tracheostomy with either a one-way speaking valve or a cap for at least 60 minutes
  • Medically cleared by the participants primary inpatient physiatry attending physician

Who cannot take part

  • Individuals with pre-morbid chronic pulmonary conditions, day-time ventilator dependence, uncontrolled autonomic dysreflexia, moderate to severe traumatic brain injury, developmental delay, diagnosis of active cancer, or secondary progressive neurologic disorder
  • Individuals with contraindications to the interventions of interest:; TSCS and Abdominal FES: pacemaker, compromised skin integrity under site of stimulation, implanted defibrillators, deep brain stimulator(s), uncontrolled epilepsy or seizures, pregnancy, recent myocardial infarct, diaphragmatic pacer; TSCS: Severe osteoporosis; Abdominal FES: unhealed rib fracture, sternal precautions, recent pneumothorax, spine bracing impacting ability to place stimulation pads
  • Individuals with medical instability impacting the safety and feasibility of participation including the inability to tolerate sitting upright >45 degrees for 15 minutes, acute unresolved medical complications as determined by study physician to be exclusionary, transferred to higher level of medical care for ≥5 consecutive days or >14 days total during trial period, and those with halo spine bracing
  • Individuals who are currently enrolled in another interventional research study are excluded from participating to eliminate potential influence of additional experimental interventions on study outcomes and to maintain standardization of study protocol

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Spinal cord injuries

Where in United States

  • Shirley Ryan AbilityLabChicago, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The overall objective of this proposal is to determine if transcutaneous spinal cord stimulation (tSCS) delivered concurrently with functional electrical stimulation (FES)-assisted cough training (FES-Cough) is an effective intervention to improve cough strength and coordination in individuals with acute/subacute SCI.

The 2 groups in the trial

  • Sham tSCS + FES-Assisted CoughSham treatment, for comparison

    In this group, the tSCS spinal stimulation will be sham, providing no additional electrical input, while the FES assisted cough intervention will remain

  • tSCS + FES-Assisted CoughExisting treatment, for comparison

    This group will receive the combination of tSCS spinal stimulation and FES assisted cough simultaneously

    Treatment: tSCS combined with FES-Cough

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Combined Transcutaneous Spinal Stimulation + FES-Assisted Cough Training in Acute SCI
Plain-language title
Spinal stimulation with electrically assisted cough training after recent spinal cord injuryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT07683780, who can take part
Record updated
6 July 2026